Cara Therapeutics Inc (CARA)
0.6843
-0.02
(-2.24%)
USD |
NASDAQ |
Apr 26, 16:00
0.6843
0.00 (0.00%)
After-Hours: 20:00
Cara Therapeutics Price to Book Value: 0.6552 for April 26, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| April 25, 2024 | 0.6702 |
| April 24, 2024 | 0.643 |
| April 23, 2024 | 0.677 |
| April 22, 2024 | 0.6993 |
| April 19, 2024 | 0.6329 |
| April 18, 2024 | 0.6606 |
| April 17, 2024 | 0.7008 |
| April 16, 2024 | 0.6788 |
| April 15, 2024 | 0.6798 |
| April 12, 2024 | 0.7316 |
| April 11, 2024 | 0.7761 |
| April 10, 2024 | 0.7775 |
| April 09, 2024 | 0.7966 |
| April 08, 2024 | 0.7904 |
| April 05, 2024 | 0.8373 |
| April 04, 2024 | 0.7907 |
| April 03, 2024 | 0.8688 |
| April 02, 2024 | 0.8804 |
| April 01, 2024 | 0.8713 |
| March 28, 2024 | 0.8713 |
| March 27, 2024 | 0.832 |
| March 26, 2024 | 0.6991 |
| March 25, 2024 | 0.785 |
| March 22, 2024 | 0.8457 |
| March 21, 2024 | 0.8537 |
| Date | Value |
|---|---|
| March 20, 2024 | 0.8644 |
| March 19, 2024 | 0.8521 |
| March 18, 2024 | 0.8688 |
| March 15, 2024 | 0.8407 |
| March 14, 2024 | 0.753 |
| March 13, 2024 | 0.8332 |
| March 12, 2024 | 0.8426 |
| March 11, 2024 | 0.9095 |
| March 08, 2024 | 0.9396 |
| March 07, 2024 | 1.005 |
| March 06, 2024 | 0.948 |
| March 05, 2024 | 0.8713 |
| March 04, 2024 | 0.9573 |
| March 01, 2024 | 0.9096 |
| February 29, 2024 | 0.8114 |
| February 28, 2024 | 0.8494 |
| February 27, 2024 | 0.9024 |
| February 26, 2024 | 0.7646 |
| February 23, 2024 | 0.8657 |
| February 22, 2024 | 0.7624 |
| February 21, 2024 | 0.6454 |
| February 20, 2024 | 0.613 |
| February 16, 2024 | 0.5976 |
| February 15, 2024 | 0.5681 |
| February 14, 2024 | 0.5393 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.3789
Minimum
Dec 21 2023
11.35
Maximum
Aug 21 2019
3.594
Average
3.294
Median
Nov 14 2022
Price to Book Value Benchmarks
| Nektar Therapeutics | 1.850 |
| Stereotaxis Inc | 11.43 |
| Cerus Corp | 5.871 |
| Avid Bioservices Inc | 2.590 |
| Rigel Pharmaceuticals Inc | -- |
Price to Book Value Related Metrics
| PS Ratio | 1.767 |
| PEG Ratio | -0.0083 |
| Price | 0.6843 |
| Earnings Yield | -320.0% |
| Market Cap | 37.40M |
| PEGY Ratio | -0.0083 |